Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Transaction in Own Shares

7 Dec 2011 07:10

null

Tate & Lyle PLC

Transaction in Own Shares

Tate & Lyle PLC (the "Company") announces that on 6 December 2011 it transferred at nil cost 813 ordinary shares in the Company for the purpose of satisfying exercises under the Tate & Lyle 2003 Performance Share Plan. These shares were previously held in Treasury.

Following the above transfer, the Company holds 547,739 ordinary shares in Treasury and has 467,602,927 ordinary shares in issue (excluding Treasury shares).

Lucie GilbertDeputy Company Secretary6 December 2011

Copyright Business Wire 2011

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.